HK1145148A1 - Solvate and crystalline forms of carbamoyl-cyclohexane derivatives - Google Patents
Solvate and crystalline forms of carbamoyl-cyclohexane derivativesInfo
- Publication number
- HK1145148A1 HK1145148A1 HK10111714.0A HK10111714A HK1145148A1 HK 1145148 A1 HK1145148 A1 HK 1145148A1 HK 10111714 A HK10111714 A HK 10111714A HK 1145148 A1 HK1145148 A1 HK 1145148A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carbamoyl
- solvate
- crystalline forms
- cyclohexane derivatives
- cyclohexane
- Prior art date
Links
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical class NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91738307P | 2007-05-11 | 2007-05-11 | |
| PCT/US2008/063181 WO2008141135A1 (en) | 2007-05-11 | 2008-05-09 | Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1145148A1 true HK1145148A1 (en) | 2011-04-08 |
Family
ID=40002604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10111714.0A HK1145148A1 (en) | 2007-05-11 | 2010-12-15 | Solvate and crystalline forms of carbamoyl-cyclohexane derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7829569B2 (xx) |
| EP (1) | EP2155200B1 (xx) |
| JP (2) | JP2010526832A (xx) |
| KR (2) | KR20150023937A (xx) |
| CN (1) | CN101801381B (xx) |
| AU (1) | AU2008251520B2 (xx) |
| CA (2) | CA2687078C (xx) |
| CY (1) | CY1118553T1 (xx) |
| DK (1) | DK2155200T3 (xx) |
| EA (1) | EA017732B1 (xx) |
| ES (1) | ES2617671T3 (xx) |
| HK (1) | HK1145148A1 (xx) |
| HR (1) | HRP20170222T1 (xx) |
| HU (1) | HUE033357T2 (xx) |
| LT (1) | LT2155200T (xx) |
| MY (1) | MY148643A (xx) |
| PL (1) | PL2155200T3 (xx) |
| PT (1) | PT2155200T (xx) |
| SI (1) | SI2155200T1 (xx) |
| WO (1) | WO2008141135A1 (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| HUP0700369A2 (en) * | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia |
| HUP0700370A2 (en) * | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania |
| US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| CA2715760C (en) * | 2008-02-21 | 2017-06-13 | Mitsubishi Tanabe Pharma Corporation | Solid preparation for oral administration of cariprazine hydrochloride |
| SG192507A1 (en) | 2008-07-16 | 2013-08-30 | Richter Gedeon Nyrt | Pharmaceutical formulations containing dopamine receptor ligands |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| WO2010128959A1 (en) | 2009-05-07 | 2010-11-11 | Halliburton Energy Services, Inc | Device orientation determination |
| WO2012063246A1 (en) * | 2010-11-11 | 2012-05-18 | Mapi Pharma Ltd. | Amorphous form of lurasidone hydrochloride |
| US8981095B2 (en) | 2011-07-28 | 2015-03-17 | Mapi Pharma Ltd. | Intermediate compounds and process for the preparation of lurasidone and salts thereof |
| WO2014031162A1 (en) * | 2012-08-20 | 2014-02-27 | Forest Laboratories Holdings Limited | Crystalline form of carbamoyl-cyclohexane derivatives |
| CN105218484B (zh) * | 2015-09-14 | 2018-02-23 | 安徽省逸欣铭医药科技有限公司 | 酒石酸卡利拉嗪及其制备方法和医药用途 |
| CN106543105B (zh) * | 2015-09-22 | 2019-10-11 | 江苏恩华药业股份有限公司 | 一种盐酸卡利拉嗪晶型ⅳ及其制备方法 |
| US20170128981A1 (en) * | 2015-11-09 | 2017-05-11 | Delavan Inc | Bulk metallic glass components |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| WO2019016828A1 (en) * | 2017-07-15 | 2019-01-24 | Msn Laboratories Private Limited, R&D Center | NOVEL PROCESSES FOR THE PREPARATION OF TRANS-N- {4- [2- [4- (2,3-DICHLOROPHENYL) PIPERAZIN-1-YL] ETHYL] CYCLOHEXYL} -N ', N'-DIMETHYLUMED HYDROCHLORIDE AND POLYMORPHS THIS ONE |
| WO2020056929A1 (zh) | 2018-09-21 | 2020-03-26 | 上海诚妙医药科技有限公司 | 卡利拉嗪盐酸盐的新晶型及其制备方法及其用途 |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| HU231500B1 (hu) | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
| WO2022042642A1 (zh) * | 2020-08-26 | 2022-03-03 | 上海博志研新药物技术有限公司 | 卡利拉嗪药物组合物、制备方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566550B2 (en) * | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| DE102004047517A1 (de) * | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
| GT200600414A (es) * | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
-
2008
- 2008-05-09 MY MYPI20094772A patent/MY148643A/en unknown
- 2008-05-09 CA CA2687078A patent/CA2687078C/en active Active
- 2008-05-09 LT LTEP08755214.7T patent/LT2155200T/lt unknown
- 2008-05-09 JP JP2010507686A patent/JP2010526832A/ja active Pending
- 2008-05-09 CN CN2008800201802A patent/CN101801381B/zh active Active
- 2008-05-09 KR KR20157002948A patent/KR20150023937A/ko not_active Application Discontinuation
- 2008-05-09 HU HUE08755214A patent/HUE033357T2/en unknown
- 2008-05-09 ES ES08755214.7T patent/ES2617671T3/es active Active
- 2008-05-09 DK DK08755214.7T patent/DK2155200T3/en active
- 2008-05-09 EP EP08755214.7A patent/EP2155200B1/en active Active
- 2008-05-09 WO PCT/US2008/063181 patent/WO2008141135A1/en active Application Filing
- 2008-05-09 CA CA2756796A patent/CA2756796C/en active Active
- 2008-05-09 US US12/117,972 patent/US7829569B2/en not_active Expired - Fee Related
- 2008-05-09 PT PT87552147T patent/PT2155200T/pt unknown
- 2008-05-09 PL PL08755214T patent/PL2155200T3/pl unknown
- 2008-05-09 KR KR1020097025993A patent/KR20100027137A/ko not_active Application Discontinuation
- 2008-05-09 EA EA200901514A patent/EA017732B1/ru unknown
- 2008-05-09 SI SI200831778A patent/SI2155200T1/sl unknown
- 2008-05-09 AU AU2008251520A patent/AU2008251520B2/en active Active
-
2010
- 2010-10-05 US US12/898,429 patent/US8609665B2/en active Active
- 2010-12-15 HK HK10111714.0A patent/HK1145148A1/xx unknown
-
2014
- 2014-02-27 JP JP2014036287A patent/JP2014129386A/ja active Pending
-
2017
- 2017-01-31 CY CY20171100137T patent/CY1118553T1/el unknown
- 2017-02-13 HR HRP20170222TT patent/HRP20170222T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101801381B (zh) | 2013-08-14 |
| CA2687078A1 (en) | 2008-11-20 |
| AU2008251520A1 (en) | 2008-11-20 |
| CY1118553T1 (el) | 2017-07-12 |
| ES2617671T3 (es) | 2017-06-19 |
| MY148643A (en) | 2013-05-15 |
| CA2756796A1 (en) | 2008-11-20 |
| EP2155200B1 (en) | 2016-12-07 |
| JP2014129386A (ja) | 2014-07-10 |
| KR20100027137A (ko) | 2010-03-10 |
| CA2756796C (en) | 2018-05-22 |
| LT2155200T (lt) | 2017-02-10 |
| PL2155200T3 (pl) | 2017-06-30 |
| EA200901514A1 (ru) | 2010-04-30 |
| SI2155200T1 (sl) | 2017-04-26 |
| CN101801381A (zh) | 2010-08-11 |
| WO2008141135A1 (en) | 2008-11-20 |
| EP2155200A4 (en) | 2012-01-04 |
| US20110028722A1 (en) | 2011-02-03 |
| CA2687078C (en) | 2012-04-10 |
| KR20150023937A (ko) | 2015-03-05 |
| US8609665B2 (en) | 2013-12-17 |
| DK2155200T3 (en) | 2017-03-13 |
| EA017732B1 (ru) | 2013-02-28 |
| US7829569B2 (en) | 2010-11-09 |
| PT2155200T (pt) | 2017-02-21 |
| AU2008251520B2 (en) | 2014-03-06 |
| HRP20170222T1 (hr) | 2017-04-07 |
| EP2155200A1 (en) | 2010-02-24 |
| HUE033357T2 (en) | 2017-11-28 |
| JP2010526832A (ja) | 2010-08-05 |
| US20090030007A1 (en) | 2009-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20170222T1 (hr) | Kristalni oblik karbamoil-cikloheksan derivata | |
| HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
| IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
| EP2188295A4 (en) | PYRIDINE DERIVATIVES AND METHODS OF USE | |
| IL210412A0 (en) | Heterocyclic derivatives and uses thereof | |
| IL198266A (en) | Crystalline acetone sulfoniferous | |
| AP2010005199A0 (en) | Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists | |
| EP2231687A4 (en) | NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES | |
| IL198262A0 (en) | Crystalline modification of fipronil | |
| ZA200903967B (en) | Crystalline modification of fipronil | |
| IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
| IL206479A0 (en) | Crystalline forms of palonosetron hydrochloride | |
| ZA200909147B (en) | IM-16 crystallized solid and method of preparation thereof | |
| HK1135972A1 (en) | 4-substituted azaadamantane derivatives and methods of use thereof 4- | |
| EP2099299A4 (en) | OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE | |
| ZA201002580B (en) | Heterocyclic derivatives | |
| EP2490541A4 (en) | 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE | |
| ZA200903972B (en) | Crystalline modification of fipronil | |
| IL215965A0 (en) | Solvate crystals and methods of producing the same | |
| EP2460812A4 (en) | STEROL DERIVATIVES AND THEIR SYNTHESIS AND USE | |
| IL196320A0 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
| IL199684A0 (en) | Methods for improved stability of steroid derivatives | |
| EP2170329A4 (en) | 7-ETHYL-10-HYDROXYCAMPTOTHECIN CRYSTALLINE POLYMORPH | |
| ZA200809112B (en) | N-oxides of pyridylmethylpiperazine and -piperidine derivatives | |
| IL195092A0 (en) | Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate |